Tamsulosin for treatment of urinary tract disorder in wome

Phase 2

Recruiting

• Conditions: Retention of urine.; R33; Retention

• Registration Number: IRCT20200111046086N1
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 April 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 252

Inclusion Criteria

Women with at least three months of urinary tract disorder
Age between 18 to 65 years old
Signing informed consent form

Exclusion Criteria

Active urinary tract infection
History of neurological disorders
Pregnant women

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
rinary symptoms (urgency; frequency; nocturia; dysuria; incomplete emptying). Timepoint: 1 Weeks after intervention. Method of measurement: Standard questionnaire (USSQ).